Malaria Vaccine Rollout Gains Momentum in Africa, Saving Lives
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Malaria Vaccine Rollout Gains Momentum in Africa, Saving Lives
-
ナレーター：
-
著者：
このコンテンツについて
On September 1, 2025, Togo officially introduced the R21 malaria vaccine into its national immunization program, marking a major milestone in the country’s public health strategy. The Ministry of Health and Hygiene’s immunization division led the initiative, emphasizing broad awareness and mobilization at a recent stakeholder meeting in Lomé. Authorities outlined that children five months and older will now systematically receive four doses of the vaccine: at five, six, seven, and fifteen months of age. The government advocates the vaccine as both safe and effective, aiming to reduce the incidence of simple and severe malaria cases among children. The R21 vaccine’s rollout is supported by the Global Alliance for Vaccines (Gavi), and executive-level meetings have reinforced partnerships at the highest political level, including recent discussions between Gavi’s CEO Sania Nishtar and Togolese President Faure Gnassingbé during the Tokyo International Conference on African Development. According to local health officials, these efforts are integrated within broader malaria prevention measures including treated mosquito nets and chemoprevention for pregnant women, reflecting a commitment to comprehensive disease control.
Simultaneously, Western Equatoria State in South Sudan is launching its first malaria vaccination campaign for children under five, spearheaded by the government in partnership with organizations such as UNICEF, World Vision, and CMMB. The campaign introduces a multi-dose regimen beginning at six months of age, followed by doses at seven, eight, and eighteen months. Health leaders in the region have stressed that malaria remains the foremost threat to child health, citing staggering statistics: in 2022, South Sudan recorded over 2.8 million malaria cases, and at least 18 children reportedly die from the disease each day. Officials describe these deaths as preventable, urging expanded vaccination coverage and support for harder-to-reach communities.
The World Health Organization and other global agencies continue to monitor and support malaria prevention strategies, including vaccine deployment. The organization notes that malaria vaccines such as Mosquirix and R21/Matrix-M are now available in several African countries, though not currently in the U.S., reflecting the regional focus of the rollout. Routine immunization programs are being adjusted to accommodate the malaria vaccine, and significant investments in training and distribution are ensuring that doses reach tens of thousands of children in the areas most in need.
These initiatives come at a time when vaccine-preventable diseases continue to threaten global health and development. The World Health Organization, the UK Health Security Agency, and other institutions emphasize staying up to date on disease outbreaks and vaccination schedules, especially for those traveling to affected regions. As efforts intensify across Togo, South Sudan, and other African nations, government leaders and health partners remain united in their mission to ensure every eligible child receives the protective benefit of malaria vaccination. The recent actions underscore a renewed commitment to reducing child mortality and confronting malaria’s persistent grip on communities during peak transmission seasons.
まだレビューはありません